Loading clinical trials...
Loading clinical trials...
In a laboratory protocol in healthy adults, exposed to a prolonged period of wakefulness with a restricted opportunity for sleep (40h of wakefulness / 3h of sleep / 21h of wakefulness), we hypothesize...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Institut de Recherche Biomedicale des Armees
Collaborators
NCT05877196 · Mild Cognitive Impairment, Alzheimer Disease, and more
NCT06223672 · Cognitive Decline, Cognitive Impairment
NCT05393830 · Sleep, Insomnia, and more
NCT06095297 · Long COVID, Brain Fog, and more
NCT07101380 · Mild Cognitive Impairment (MCI)
Institut de recherche biomédical des armées
Brétigny-sur-Orge
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions